Page last updated: 2024-10-31

metoprolol and Cerebral Infarction, Middle Cerebral Artery

metoprolol has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
" Finally, animals were treated with metoprolol to evaluate a pharmacologic treatment option to prevent the development of heart failure."3.85Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity. ( Bieber, M; Frantz, S; Heuschmann, PU; Higuchi, T; Hofmann, U; Kleinschnitz, C; Kraft, P; Ritter, O; Schuh, K; Tanai, E; Werner, RA, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bieber, M1
Werner, RA1
Tanai, E1
Hofmann, U1
Higuchi, T1
Schuh, K1
Heuschmann, PU1
Frantz, S1
Ritter, O1
Kraft, P1
Kleinschnitz, C1

Other Studies

1 other study available for metoprolol and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity.
    Annals of neurology, 2017, Volume: 82, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Brain Ischemia; Echocardiography; Epinephrine; Hear

2017